{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:09:43Z","timestamp":1788786583756,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["JCYJ20250604185402003"],"award-info":[{"award-number":["JCYJ20250604185402003"]}]},{"name":"Shenzhen Longgang District Science & Technology Innovation Special Fund\u2013Medical & Health Technology Research Project","award":["LGKCYLWS2023033"],"award-info":[{"award-number":["LGKCYLWS2023033"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Young children are at high risk of influenza and its complications, yet evidence on the real-world effectiveness of egg-based inactivated influenza vaccines in children aged 6\u201359 months remains limited during antigenically drifted seasons. Methods: We conducted a population-based retrospective cohort study using linked immunization and influenza surveillance records from 4 August 2025 to 8 February 2026. Vaccinated and unvaccinated children aged 6\u201359 months were matched 1:1 using propensity scores based on demographic characteristics, routine and non-routine vaccination history, prior seasonal influenza vaccination (SIV), and prior influenza infection. For vaccinated children, the index date was defined as the date of the last SIV received during the study period; matched unvaccinated children were assigned the corresponding index date. Follow-up began 14 days later and continued until influenza onset or 8 February 2026. Adjusted vaccine effectiveness (aVE) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. Sensitivity analyses included a negative control outcome analysis using varicella infection, a multivariable logistic regression analysis with influenza infection as the outcome, and a time-dependent exposure Cox regression analysis in the full eligible cohort. Results: A total of 26,444 children were included in the final cohort (13,239 vaccinated and 13,205 unvaccinated). Influenza incidence rates were 28.70 and 40.21 per 100 person-years in vaccinated and unvaccinated groups, respectively. The aVE was 28.82% (95% CI: 23.07\u201334.14%). aVE was generally consistent across most subgroups, but was lower in children vaccinated in the previous season than in those without prior-season vaccination (20.41% vs. 34.28%; p for interaction = 0.016). Sensitivity analyses yielded comparable VE estimates. Conclusions: Egg-based inactivated influenza vaccination conferred moderate real-world protection against influenza in children aged 6\u201359 months during the 2025\/26 season. Continued monitoring of vaccine effectiveness is needed to inform vaccination strategies in young children.<\/jats:p>","DOI":"10.3390\/vaccines14090762","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:31:13Z","timestamp":1788251473000},"page":"762","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Effectiveness of Egg-Based Inactivated Influenza Vaccines Against Influenza Among Children Aged 6\u201359 Months During the 2025\/26 Season in Shenzhen Area, China: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Hui-Ling","family":"Tan","sequence":"first","affiliation":[{"name":"Longgang District Center for Disease Control and Prevention, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-4425","authenticated-orcid":false,"given":"Wu","family":"Li","sequence":"additional","affiliation":[{"name":"Longgang District Center for Disease Control and Prevention, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Longgang District Center for Disease Control and Prevention, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Rui-Kun","family":"Zeng","sequence":"additional","affiliation":[{"name":"Longgang District Center for Disease Control and Prevention, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Jia-Xin","family":"Zhong","sequence":"additional","affiliation":[{"name":"School of Public Health, Guangdong Medical University, Dongguan 523808, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Hou-Ming","family":"Wei","sequence":"additional","affiliation":[{"name":"Longgang District Center for Disease Control and Prevention, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: A modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"ref_2","unstructured":"World Health Organization (2025, February 28). Influenza (Seasonal), Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2550092","DOI":"10.1080\/21645515.2025.2550092","article-title":"Disease burden of seasonal influenza in China from 2010 to 2019: A systematic review and meta-analysis based on multiple indicators","volume":"21","author":"Zhang","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: A systematic review and modelling study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_5","unstructured":"National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG (2025). Technical guidelines for seasonal influenza vaccination in China (2025\u20132026). Zhonghua Liu Xing Bing Xue Za Zhi, 46, 2097\u20132107. (In Chinese)."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1080\/21645515.2019.1705692","article-title":"A model of influenza infection and vaccination in children aged under 5 years in Beijing, China","volume":"16","author":"Zhang","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control (2025, November 17). Survey Report on National Seasonal Influenza Vaccination Recommendations and Coverage Rates in EU\/EEA Countries, 2024\/25, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/survey-report-national-seasonal-influenza-vaccination-recommendations-and."},{"key":"ref_8","unstructured":"Kahn, K.E.J.A., Zhou, T.Y., Hung, M.C., Srivastav, A., Lu, P.J., Kriss, J.L., Black, C.L., and Singleton, J.A. (2026, January 08). Flu Vaccination Coverage, United States, 2024\u201325 Influenza Season, Available online: https:\/\/www.cdc.gov\/fluvaxview\/coverage-by-season\/2024-2025.html."},{"key":"ref_9","first-page":"2400618","article-title":"Effectiveness of influenza vaccines in children aged 6 to 59 months: A test-negative case-control study at primary care and hospital level, Spain 2023\/24","volume":"29","author":"Mazagatos","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114558","DOI":"10.1016\/j.jpeds.2025.114558","article-title":"Effectiveness of Influenza Vaccination in Children Aged 6\u201359 Months during the Inaugural 2022\u20132023 Season in Andalusia, Spain","volume":"282","author":"Lorusso","year":"2025","journal-title":"J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2452512","DOI":"10.1001\/jamanetworkopen.2024.52512","article-title":"Estimated Vaccine Effectiveness for Pediatric Patients with Severe Influenza, 2015\u20132020","volume":"7","author":"Sumner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tricco, A.C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M.H., Tashkandi, M., Bauch, C.T., and Loeb, M. (2013). Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-153"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2535250","DOI":"10.1001\/jamanetworkopen.2025.35250","article-title":"Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza: A Systematic Review and Meta-Analysis","volume":"8","author":"Goldsmith","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-2600(22)00266-1","article-title":"Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis","volume":"11","author":"Robinson","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e1364","DOI":"10.1093\/infdis\/jiag051","article-title":"Repeat influenza vaccination effects in 2021\/22 and 2022\/23 in a community-based cohort in Hong Kong","volume":"233","author":"Zhong","year":"2026","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofae175","DOI":"10.1093\/ofid\/ofae175","article-title":"Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States","volume":"11","author":"Stein","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.vaccine.2024.02.056","article-title":"Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June\u2013November 2023","volume":"42","author":"Murphy","year":"2024","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e077076","DOI":"10.1136\/bmj-2023-077076","article-title":"Optimal timing of influenza vaccination in young children: Population based cohort study","volume":"384","author":"Worsham","year":"2024","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.2025.25903","article-title":"Influenza A(H3N2) Subclade K Virus: Threat and Response","volume":"335","author":"Zambon","year":"2026","journal-title":"JAMA"},{"key":"ref_20","unstructured":"World Health Organization (2025, February 28). Recommended Composition of Influenza Virus Vaccines for Use in the 2025\u20132026 Northern Hemisphere Influenza Season, Available online: https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season."},{"key":"ref_21","unstructured":"World Health Organization (2025, September 26). Recommended Composition of Influenza Virus Vaccines for Use in the 2026 Southern Hemisphere Influenza Season, Available online: https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-southern-hemisphere-influenza-season."},{"key":"ref_22","first-page":"2500992","article-title":"Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026","volume":"31","author":"Blanquart","year":"2026","journal-title":"Eurosurveillance"},{"key":"ref_23","first-page":"2600096","article-title":"Modest protection from vaccination against influenza A(H3N2) subclade K, Beijing, China, 2025\/26 season","volume":"31","author":"Shen","year":"2026","journal-title":"Eurosurveillance"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2500854","DOI":"10.2807\/1560-7917.ES.2025.30.46.2500854","article-title":"Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K","volume":"30","author":"Kirsebom","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2370087","DOI":"10.1080\/21645515.2024.2370087","article-title":"Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults","volume":"20","author":"Boyce","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41467-023-44551-x","article-title":"Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_27","unstructured":"National Health Commission of the People\u2019s Republic of China, and State Administration of Traditional Chinese Medicine (2025). Protocol for diagnosis and treatment of influenza (2025 version). Chin. J. Clin. Infect. Dis., 18, 1\u20136. (In Chinese)."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/ciae375","article-title":"Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022\u20132023 Influenza Season Among Adults \u226565 Years of Age","volume":"79","author":"Ku","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","unstructured":"World Health Organization (2025, December 10). Seasonal Influenza\u2014Global Situation, Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON586."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2600068","DOI":"10.2807\/1560-7917.ES.2026.31.5.2600068","article-title":"Interim 2025\/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026","volume":"31","author":"Separovic","year":"2026","journal-title":"Eurosurveillance"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.15585\/mmwr.mm7509a2","article-title":"Interim Estimates of 2025\u201326 Seasonal Influenza Vaccine Effectiveness\u2014United States, September 2025\u2013February 2026","volume":"75","author":"Maloney","year":"2026","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2490531","DOI":"10.1080\/22221751.2025.2490531","article-title":"Influenza vaccine effectiveness among primary and secondary school students in Shenzhen during the 2023\/24 influenza season","volume":"14","author":"Jiang","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhu, L.Y., Han, Y., Lu, J.H., Tan, J.H., Liao, C.H., Guo, C., He, Q., Qiu, Y.J., Lu, H.H., and Zhou, Y. (2024). Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case-Control Study. Vaccines, 13.","DOI":"10.3390\/vaccines13010004"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/762\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:34:40Z","timestamp":1788784480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090762"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090762","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}